Black Diamond Therapeutics
BDTX
BDTX
102 hedge funds and large institutions have $91.8M invested in Black Diamond Therapeutics in 2025 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.79% less ownership
Funds ownership: 68.11% → 66.32% (-1.8%)
38% less capital invested
Capital invested by funds: $147M → $91.8M (-$55.1M)
Holders
102
Holding in Top 10
–
Calls
$657K
Puts
$235K
Top Buyers
| 1 | +$4.07M | |
| 2 | +$2.57M | |
| 3 | +$1.85M | |
| 4 |
D.E. Shaw & Co
New York
|
+$1.81M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.51M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$7.85M | |
| 3 | -$1.96M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.31M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.16M |
